Saulat Rehan

Saulat Rehan serves as a key procurement professional within the Centers for Disease Control and Prevention, supporting the agency’s mission to safeguard public health through strategic acquisition of critical biomedical and diagnostic resources. Responsible for managing complex contracting actions, Rehan oversees the procurement of laboratory instruments, in-vitro diagnostic substances, and specialized medical supply chains essential to national disease surveillance and outbreak response. Their work directly enables CDC’s operational capacity in laboratory diagnostics, real-time data collection, and emergency preparedness, ensuring timely access to high-integrity scientific equipment and biological testing materials. Rehan maintains longstanding relationships with leading global pharmaceutical and medical technology providers, including Merck Sharp & Dohme LLC, GlaxoSmithKline LLC, Pfizer Inc., Sanofi Pasteur Inc., and McKesson Specialty Distribution LLC. These partnerships reflect a focus on large-scale, high-compliance vendors capable of delivering regulated biological products, diagnostic reagents, and cold-chain distribution services under stringent federal quality and safety standards. The contracting pattern emphasizes reliability, regulatory compliance, and supply chain resilience over competitive bidding, consistent with the mission-critical nature of CDC’s public health mandates. Rehan’s procurement portfolio shows no use of socioeconomic set-asides, with 100% of awards issued under full and open competition. This reflects a deliberate alignment with CDC’s operational imperatives, where technical specificity, regulatory certifications, and global manufacturing scale outweigh small business participation goals. The absence of 8(a), HUBZone, or SDVOSB preferences underscores a prioritization of technical capability and supply chain continuity in life-saving public health procurement. The primary NAICS focus areas center on analytical laboratory instrument manufacturing (334516) and in-vitro diagnostic substance manufacturing (325413), indicating deep expertise in procuring precision diagnostic equipment and biological testing kits. Additional activity in professional equipment wholesaling (423490) and specialized measuring device manufacturing (334519) reinforces a technical domain focused on clinical diagnostics, laboratory automation, and biosafety-critical instrumentation. Rehan’s work is anchored in the scientific and regulatory demands of infectious disease control and public health emergency response.